Novel process and intermediates

a technology of thioates and thioates, applied in the field of process for the preparation of steroidal 17carboxylic thioates, can solve the problems of affecting the quality of steroids, and affecting the effect of endocrine system disorder, so as to achieve convenient commercial scale production and convenient and efficient

Active Publication Date: 2009-07-09
GENERICS UK LTD
View PDF3 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0031]It is a further object of the present invention to provide a convenient and efficient synthesis of fluticasone propionate I using soluble mixed fluorides resulting in selective and controlled fluorination.
[0032]Another object of the present invention is to provide a process for the preparation of fluticasone propionate I, which is convenient for commercial scale production and does not involve any tedious operations such as chromatographic separation.

Problems solved by technology

Processes for the synthesis of fluticasone propionate I are known in the prior art, but are associated with various difficulties.
Even though the process described above is eco-friendly, it is not capable of providing fluticasone propionate I sufficiently pure to meet the limits of stringent pharmacopoeial specifications (EP / USP), and the processing conditions for the conversion of chloromethyl ester 5 to iodomethyl ester 6 and then to fluticasone propionate I are very tedious and inefficient.
The conversion of iodomethyl ester 6 to fluticasone propionate I disclosed in U.S. Pat. No. 4,335,121 suffers from the following limitations:The reaction takes a long time (72 hours-11 days).An excess of silver fluoride (10-15 eq) must be used for complete conversion, which causes problems during recovery of the silver fluoride from the waste stream.Because of the excess of silver fluoride used, a thick black insoluble residue forms, which interferes in the homogeneity of the reaction.The black suspended metallic particles cannot be eliminated easily by Kieselguhr filtration, where these impurities are carried forward even after multiple filtrations.
This chromatographic purification further limits the applicability of this process on a commercial scale.
The disadvantage of this process is the use of halofluoromethanes, such as bromofluoromethane, which are non-eco-friendly reagents known to damage the ozone layer of the atmosphere.
Although the process described in EP 1431305 is capable of producing relatively pure fluticasone propionate I, a drawback associated with this process is the oxidative dimerisation of the sulphur compounds to give dimer impurities 11 and 12, especially under pressure or with long reaction times. Such by-products are formed in significant amounts, which are difficult to control / reduce within the limits of stringent pharmacopoeial specifications even after multiple purifications.
The use of hazardous DAST® as a fluorinating agent and the use of highly corrosive hydrofluoric acid are major disadvantages of this process described in WO 2004 / 052912.
Thus the prior art processes described above for the synthesis of fluticasone propionate I suffer from various limitations with respect to process parameters, yields, purity and quality, as well as serious environmental issues due to the use of halofluoromethanes.
However, the purification of this key intermediate, i.e. iodomethyl ester 6, is not disclosed in any of the literature, and in particular not in U.S. Pat. No. 4,335,121.
In addition, iodomethyl ester 6, the dimer impurities and other non-polar related impurities have poor solubility in polar as well as non-polar solvents and therefore the purification of iodomethyl ester 6 by crystallisation or chromatographic separation becomes very tedious and uneconomic.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel process and intermediates
  • Novel process and intermediates
  • Novel process and intermediates

Examples

Experimental program
Comparison scheme
Effect test

example a

[0129]A solution of mixed fluorides was obtained by refluxing silver fluoride (10.0 eq) and calcium fluoride (10.0 eq) in acetonitrile at 90-95° C. for 4 hours, followed by filtration. Compound 6 was charged at −10 to −15° C. into the solution obtained and the reaction mixture was stirred for 36 hours at −10 to −15° C. Then further silver fluoride (2.0 eq) was added and the reaction mixture was stirred for a further 12 hours at −10 to −15° C. Crude fluticasone propionate I was isolated by aqueous extraction work up using ethyl acetate, Na2CO3, 2M HCl and water. Distillation of the ethyl acetate, followed by swapping with diisopropyl ether gave colourless fluticasone propionate I. By following this procedure, crude fluticasone propionate I was obtained with more than 98% HPLC purity consistently (Table 4).

TABLE 4HPLC purity%(area %) of crudeYieldfluticasoneExp no.Reaction conditions(w / w)propionate IExp-1acetonitrile filtrate of AgF (10.0 eq)6098.15and CaF2 (10.0 eq), S-iodo compound6...

example b

[0130]Fluticasone propionate I obtained from the above example was further crystallised using methanol (55 vol) at 60-65° C. The clear solution was treated with activated carbon and then filtered. By chilling the resulting solution to 0 to −5° C. for maximum isolation, pure product was isolated. This was dried under reduced pressure at 50-55° C. This gave fluticasone propionate I with more than 99% HPLC purity and conforming to the EP 5.0 and USP 29 specifications. The non-polar dimeric impurities (impurities H and I in EP 5.0; impurities D and E in USP 29) were significantly below (˜0.10%) the specified pharmacopoeial limit (0.2% in EP 5.0, 0.3% in USP 29), see Table 5.

TABLE 5Crystallisation%HPLC purity (area %) of purifiedsolventsYieldfluticasone propionate I and RRTExp no.and conditions(w / w)of impurities wrt EP 5.0 / USP 29Exp-1Methanol (55 vol),71Related substances as per EP 5.0reflux at 60-65° C.,fluticasone propionate I: 99.52activated carbon,Impurity C: 0.10chilling to 0 toImpu...

example 1

Preparation of Iodomethyl Ester 6 from Chloromethyl Ester 5

[0131]Sodium iodide (4.0 eq) was charged to acetone (20 vol) under stirring. Butylated hydroxytoluene (BHT) (1.0 eq) and hydroquinone (1.0 eq) were added to the stirred suspension of sodium iodide at 25-30° C. The reaction mixture was stirred for 30 minutes. Chloromethyl ester 5 (1.0 eq) was added to this stirred suspension and the reaction mixture was refluxed for 24 hours at 60-65° C. After completion of the reaction, the product was isolated by distillation of acetone and precipitation by adding 5% w / v solution of NaHCO3. The crude iodomethyl ester 6 was filtered, washed with water (3×10 vol) and dried under reduced pressure (˜100 mm of Hg) at 55-60° C. for 4 hours. Yield: 75-85% w / w. HPLC purity: 96-97%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a process for the preparation of steroidal 17β-carboxylic thioates. More particularly the present invention relates to a convenient and efficient synthesis of steroidal 17β-carboxylic thioates, such as fluticasone propionate I, using soluble mixed fluorides to introduce fluorine by displacing an appropriate leaving group X in compounds II resulting in selective and controlled fluorination. The present invention also relates to intermediates II and their preparation.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of International Patent Application No. PCT / GB2007 / 050328, filed on, Jun. 11, 2007, which claims priority to Indian Application No. 937 / mum / 2006, filed on Jun. 14, 2006, and Indian Application No. 938 / mum / 2006, filed on Jun. 14, 2006, the entire contents of both of which are incorporated herein by reference.FIELD OF THE INVENTION[0002]The present invention relates to a process for the preparation of steroidal 17β-carboxylic thioates. More particularly the present invention relates to a convenient and efficient synthesis of steroidal 17β-carboxylic thioates, such as fluticasone propionate I, using soluble mixed fluorides to introduce fluorine by displacing an appropriate leaving group X in compounds II resulting in selective and controlled fluorination. The present invention also relates to intermediates II and their preparation.BACKGROUND OF THE INVENTION[0003]Fluticasone propionate I, chemically known a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07J31/00
CPCC07J3/00C07J31/006A61P5/00A61P5/44
Inventor GORE, VINAYAK G.GADAKAR, MAHESHPOKHARKAR, K.WAKCHURE, V.
Owner GENERICS UK LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap